ATE323706T1 - Pyrazolopyridazinderivate - Google Patents

Pyrazolopyridazinderivate

Info

Publication number
ATE323706T1
ATE323706T1 AT02805104T AT02805104T ATE323706T1 AT E323706 T1 ATE323706 T1 AT E323706T1 AT 02805104 T AT02805104 T AT 02805104T AT 02805104 T AT02805104 T AT 02805104T AT E323706 T1 ATE323706 T1 AT E323706T1
Authority
AT
Austria
Prior art keywords
pyrazolopyridazine derivatives
pyrazolopyridazine
derivatives
Prior art date
Application number
AT02805104T
Other languages
German (de)
English (en)
Inventor
Phillip Anthony Harris
David Kendall Jung
Michael Robert Peel
Michael John Reno
Tara Renae Rheault
Jennifer G Badiang
Kirk Lawrence Stevens
James Marvin Veal
Francis Xavier Tavares
Scott Howard Dickerson
Original Assignee
Smithkline Beecham Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Corp filed Critical Smithkline Beecham Corp
Application granted granted Critical
Publication of ATE323706T1 publication Critical patent/ATE323706T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AT02805104T 2001-12-17 2002-12-11 Pyrazolopyridazinderivate ATE323706T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US34179801P 2001-12-17 2001-12-17

Publications (1)

Publication Number Publication Date
ATE323706T1 true ATE323706T1 (de) 2006-05-15

Family

ID=23339081

Family Applications (1)

Application Number Title Priority Date Filing Date
AT02805104T ATE323706T1 (de) 2001-12-17 2002-12-11 Pyrazolopyridazinderivate

Country Status (10)

Country Link
US (1) US7279473B2 (enExample)
EP (1) EP1463730B1 (enExample)
JP (1) JP2005524609A (enExample)
AR (1) AR037826A1 (enExample)
AT (1) ATE323706T1 (enExample)
AU (1) AU2002357164A1 (enExample)
DE (1) DE60210819T2 (enExample)
ES (1) ES2262899T3 (enExample)
TW (1) TW200301119A (enExample)
WO (1) WO2003051886A1 (enExample)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20060111716A (ko) 2002-01-22 2006-10-27 워너-램버트 캄파니 엘엘씨 2-(피리딘-2-일아미노)-피리도[2,3-ｄ]피리미딘-7-온
JP2006504755A (ja) * 2002-10-15 2006-02-09 スミスクライン ビーチャム コーポレーション Ｇｓｋ−３阻害薬としてのピリダジン化合物
PL1648889T3 (pl) * 2003-07-11 2009-03-31 Warner Lambert Co Sól izetionian selektywnego inhibitora CDK4
DE10344223A1 (de) * 2003-09-24 2005-04-21 Merck Patent Gmbh 1,3-Benzoxazolylderivate als Kinase-Inhibitoren
WO2006050076A1 (en) 2004-10-29 2006-05-11 Janssen Pharmaceutica, N.V. Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders
TW200800213A (en) 2005-09-02 2008-01-01 Abbott Lab Novel imidazo based heterocycles
JP5179509B2 (ja) * 2006-12-08 2013-04-10 エフ．ホフマン−ラ ロシュ アーゲー 置換ピリミジン類及びｊｎｋモジュレーターとしてのこれらの使用
EP2231636B1 (en) * 2007-12-07 2011-09-14 Novartis AG Pyrazole derivatives and use thereof as inhibitors of cyclin dependent kinases
LT2265607T (lt) 2008-02-15 2017-03-27 Rigel Pharmaceuticals, Inc. Pirimidin-2-amino junginiai ir jų panaudojimas kaip jak kinazių slopiklių
ME02154B (me) * 2008-06-30 2015-10-20 Janssen Pharmaceutica Nv Proces za pripremu supstituisanih derivata pirimidina
AR074870A1 (es) * 2008-12-24 2011-02-16 Palau Pharma Sa Derivados de pirazolo (1,5-a ) piridina
JP5959537B2 (ja) * 2011-01-28 2016-08-02 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 置換ピリジニル−ピリミジン及び医薬としてのその使用
US20150203812A1 (en) * 2014-01-20 2015-07-23 Francesco Tombola Inhibitors of Voltage Gated Ion Channels
GB201605126D0 (en) 2016-03-24 2016-05-11 Univ Nottingham Inhibitors and their uses
CN106699608A (zh) * 2016-12-26 2017-05-24 常州大学 一种含有强吸电子基团的苯胍及其盐的制备方法
GB201715342D0 (en) 2017-09-22 2017-11-08 Univ Nottingham Compounds
US11066404B2 (en) 2018-10-11 2021-07-20 Incyte Corporation Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors
WO2020168197A1 (en) 2019-02-15 2020-08-20 Incyte Corporation Pyrrolo[2,3-d]pyrimidinone compounds as cdk2 inhibitors
US11472791B2 (en) 2019-03-05 2022-10-18 Incyte Corporation Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors
WO2020205560A1 (en) 2019-03-29 2020-10-08 Incyte Corporation Sulfonylamide compounds as cdk2 inhibitors
US11447494B2 (en) 2019-05-01 2022-09-20 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
US11440914B2 (en) 2019-05-01 2022-09-13 Incyte Corporation Tricyclic amine compounds as CDK2 inhibitors
CN114269742B (zh) * 2019-07-10 2024-07-16 常州千红生化制药股份有限公司 作为治疗剂的4-(咪唑并[1,2-a]吡啶-3-基)-N-(吡啶基)嘧啶-2-胺的衍生物
BR112022002698A2 (pt) 2019-08-14 2022-07-19 Incyte Corp Compostos de imidazolil pirimidinilamina como inibidores de cdk2
AU2020364007A1 (en) 2019-10-11 2022-04-28 Incyte Corporation Bicyclic amines as CDK2 inhibitors
US11981671B2 (en) 2021-06-21 2024-05-14 Incyte Corporation Bicyclic pyrazolyl amines as CDK2 inhibitors
US12084453B2 (en) 2021-12-10 2024-09-10 Incyte Corporation Bicyclic amines as CDK12 inhibitors
US11976073B2 (en) 2021-12-10 2024-05-07 Incyte Corporation Bicyclic amines as CDK2 inhibitors
CN118005948B (zh) * 2024-04-09 2024-06-28 蓝固(湖州)新能源科技有限公司 一种电解液添加剂及其制备方法和应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU622330B2 (en) 1989-06-23 1992-04-02 Takeda Chemical Industries Ltd. Condensed heterocyclic compounds having a nitrogen atom in the bridgehead for use as fungicides
EP0984692A4 (en) 1997-05-30 2001-02-21 Merck & Co Inc ANGIOGENESIS INHIBITORS
ATE281458T1 (de) 1997-09-05 2004-11-15 Glaxo Group Ltd Pharmazeutische zusammensetzung, enthaltend 2,3- diaryl-pyrazolo(1,5-b)pyridazin derivate
WO1999032447A2 (en) 1997-12-11 1999-07-01 American Home Products Corporation 2,4,6-trisubstituted pyridines with estrogenic activity and methods for the solid phase synthesis thereof
GB9919778D0 (en) * 1999-08-21 1999-10-27 Zeneca Ltd Chemical compounds
PT1140939E (pt) 1999-11-10 2005-05-31 Ortho Mcneil Pharm Inc 2-aril-3-(heteroaril)- imidazo [1,2-alfa] pirimidinas substituidas, e formulacoes farmaceuticas e metodos relacionados
US6638926B2 (en) 2000-09-15 2003-10-28 Vertex Pharmaceuticals Incorporated Pyrazole compounds useful as protein kinase inhibitors
GB0103926D0 (en) 2001-02-17 2001-04-04 Astrazeneca Ab Chemical compounds

Also Published As

Publication number Publication date
WO2003051886A1 (en) 2003-06-26
AU2002357164A8 (en) 2003-06-30
AR037826A1 (es) 2004-12-09
ES2262899T3 (es) 2006-12-01
JP2005524609A (ja) 2005-08-18
DE60210819D1 (en) 2006-05-24
US7279473B2 (en) 2007-10-09
EP1463730B1 (en) 2006-04-19
US20050090507A1 (en) 2005-04-28
TW200301119A (en) 2003-07-01
WO2003051886A8 (en) 2004-08-19
AU2002357164A1 (en) 2003-06-30
EP1463730A1 (en) 2004-10-06
DE60210819T2 (de) 2007-04-19

Similar Documents

Publication Publication Date Title
ATE323706T1 (de) Pyrazolopyridazinderivate
ATE319451T1 (de) Tetrahydrochinolin-derivate
DE60208775D1 (de) Formgedächtnisstyrolcopolymer
DE60237988D1 (de) Enstands
ATE312827T1 (de) 3-substituierte-4-pyrimidonderivate
EP1440774A4 (en) BIOFUEL HUMANOID ROBOT
DE60233524D1 (de) Imediadaten
DE50209238D1 (de) Kugelgelenk
DE60135540D1 (de) noporen
DE60225606D1 (de) Perfluoroelastomere
DE60233923D1 (de) raftstoffrückführung
DE60231527D1 (de) Aerosolspritzdüse
DE60232493D1 (de) Tikgetriebes
DE50208372D1 (de) Schrankaufhängevorrichtung
DE60208269D1 (de) Flüssigkeitsströmungsreguliersystem
DE60233205D1 (de) Albtonpunkten
DE50214628D1 (de) Ckaufbaudynamik
DE60214306D1 (de) Schwimbrille
DE60223031D1 (de) Arylpiperazin gebundene tetrahydroindolonderivate
DE60233454D1 (de) Wirbelstromprüfsonde
ATE355059T1 (de) Isoxazolopyridinone
DE60201845D1 (de) Buschschneider
DE60203465D1 (de) Dosierungssytem
DE60235709D1 (de) Vorformapperat
DE60219260D1 (de) Garnaufwickelmaschine

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties